Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 8;10(5):1136.
doi: 10.3390/jcm10051136.

Prognostic Markers for Chorioamnionitis: IL-6, TNF-α, and MMP-8 in Vaginally Obtained Amniotic Fluid

Affiliations

Prognostic Markers for Chorioamnionitis: IL-6, TNF-α, and MMP-8 in Vaginally Obtained Amniotic Fluid

Greta Balciuniene et al. J Clin Med. .

Abstract

Background: Earlier chorioamnionitis diagnosis is crucial to improve maternal and neonatal health outcomes. This study was conducted to evaluate the inlerleukin-6 (IL-6), tumor necrosis factor α (TNF-α), and matrix metalloproteinase 8 (MMP-8) levels in vaginally obtained amniotic fluid to investigate their prognostic value and to determine the most appropriate cut-off values for the prediction of chorioamnionitis.

Methods: This case control study included women who were diagnosed with preterm premature rupture of the membranes before 34 weeks of gestation and were admitted to Vilnius University Hospital Santaros Klinikos. Free-leaking amniotic fluid was obtained vaginally with a sterile speculum less than 48h before delivery. Amniotic fluid IL-6, TNF-α, and MMP-8 levels were determined by the Enzyme Linked Immunosorbent Assay. Diagnosis of chorioamnionitis was confirmed by histological examination of the placenta and membranes after delivery.

Results: The study included 156 women, 65 patients in the histological chorioamnionitis group (Group I) and 91 in a group without diagnosed histological chorioamnionitis (Group II). The median concentrations of IL-6, MMP-8, and TNF-α in amniotic fluid were statistically significantly higher in Group I than in Group II (p-value < 0.001). The area under the curve of TNF-α and MMP-8 were higher than the area under the curve of IL-6 (0.91, 0.89, and 0.81, respectively). No statistically significant difference was found when comparing the receiver operating characteristic (ROC) curves of TNF-α and MMP-8. The optimum cut-off values for the prediction of chorioamnionitis were found to be 1389.82 pg/mL for IL-6, 21.17 pg/mL for TNF-α, and 172.53 ng/mL for MMP-8. The sensitivity, specificity, positive prognostic value (PPV), and negative prognostic value (NPV) of the IL-6 cut-off for chorioamnionitis were 88%, 70%, 67%, and 89%, respectively. The sensitivity, specificity, PPV, and NPV of the TNF-α cut-off were 88%, 84%, 79%, and 90%, respectively. The sensitivity, specificity, PPV, and NPV of the MMP-8 cut-off were 80%, 87%, 81%, and 86%, respectively.

Conclusions: The vaginally obtained amniotic fluid IL-6, MMP-8, and TNF-α seem to be good predictors for chorioamnionitis of patients with preterm premature rupture of membranes before 34 weeks of gestation. The noninvasive technique of sampling amniotic fluid could be alternative method to invasive amniocentesis.

Keywords: IL-6; MMP-8; TNF-α; chorioamnionitis; immunological markers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Interleukin-6 (IL-6), matrix metalloproteinase 8 (MMP-8), and tumor necrosis factor alpha (TNF-α) concentrations in amniotic fluid. Women with the presence of histological chorioamnionitishad a higher median of IL-6, MMP-8, and TNF- α concentrations than women without histological chorioamnionitis. p-value < 0.001 for all 3 assays. Horizontal bars indicate the median values. Group I, patients with diagnosed histological chorioamnionitis and Group II, patients without diagnosed histological chorioamnionitis.
Figure 2
Figure 2
Comparison of the receiver operating characteristic (ROC) curves of IL-6, MMP-8, and TNF-α. AUC, area under the curve.

Similar articles

Cited by

References

    1. Tita A.T.N., Andrews W.W. Diagnosis and Management of Clinical Chorioamnionitis. Clin. Perinatol. 2010;37:339–354. doi: 10.1016/j.clp.2010.02.003. - DOI - PMC - PubMed
    1. Mercer B.M. Preterm premature rupture of the membranes. Obstet. Gynecol. 2003;101:178–193. - PubMed
    1. Shatrov J.G., Birch S.C.M., Lam L.T., Quinlivan J.A., McIntyre S., Mendz G.L. Chorioamnionitis and cerebral palsy: A meta-analysis. Obstet. Gynecol. 2010;116:387–392. doi: 10.1097/AOG.0b013e3181e90046. - DOI - PubMed
    1. Ericson J.E., Laughon M.M. Chorioamnionitis: Implications for the neonate. Clin. Perinatol. 2015;42:155–165. doi: 10.1016/j.clp.2014.10.011. - DOI - PMC - PubMed
    1. Gibbs R.S. Diagnosis of intra-amniotic infection. Semin. Perinatol. 1977;1:71–77. - PubMed

LinkOut - more resources